ADJUSTING OVERALL SURVIVAL ESTIMATES AFTER TREATMENT SWITCHING IN PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE SERAPHIN RANDOMIZED STUDY

被引：0
|
作者：
Di Scala, L. [1 ]
Bacchi, M. [2 ]
Bayer, B. [3 ]
Turricchia, S. [4 ]
机构：
[1] Janssen Global Serv Hlth Econ & RWE, Allschwil, BL, Switzerland
[2] Actel Pharmaceut Ltd, Stat & Decis Sci, Allschwil, BL, Switzerland
[3] Actel Pharmaceut Ltd, Global Market Access & Pricing, Allschwil, BL, Switzerland
[4] Actel Pharmaceut Ltd, Global Med Affairs, Allschwil, BL, Switzerland
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO112
引用
收藏
页码：S325 / S325
页数：1
相关论文
共 50 条
  • [31] INITIAL TREATMENT COMBINATION WITH MACITENTAN AND TADALAFIL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE OPTIMA STUDY
    Sitbon, Olivier
    Canuet, Matthieu
    Picard, Francois
    Gregoire, Prevot
    Bergot, Emmanuel
    Cottin, Vincent
    Bauer, Fabrice
    Degano, Bruno
    Gressin, Virginie
    Perchenet, Loic
    Clerson, Pierre
    Simonneau, Gerald
    CHEST, 2019, 156 (04) : 870A - 871A
  • [32] Anticoagulation and Survival in Pulmonary Arterial Hypertension Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
    Olsson, Karen M.
    Delcroix, Marion
    Ghofrani, H. Ardeschir
    Tiede, Henning
    Huscher, Doerte
    Speich, Rudolf
    Gruenig, Ekkehard
    Staehler, Gerd
    Rosenkranz, Stephan
    Halank, Michael
    Held, Matthias
    Lange, Tobias J.
    Behr, Juergen
    Klose, Hans
    Claussen, Martin
    Ewert, Ralf
    Opitz, Christian F.
    Vizza, C. Dario
    Scelsi, Laura
    Vonk-Noordegraaf, Anton
    Kaemmerer, Harald
    Gibbs, J. Simon R.
    Coghlan, Gerry
    Pepke-Zaba, Joanna
    Schulz, Uwe
    Gorenflo, Matthias
    Pittrow, David
    Hoeper, Marius M.
    CIRCULATION, 2014, 129 (01) : 57 - +
  • [33] Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland
    Ling, Yi
    Johnson, Martin K.
    Kiely, David G.
    Condliffe, Robin
    Elliot, Charlie A.
    Simon, J.
    Gibbs, R.
    Howard, Luke S.
    Pepke-Zaba, Joanna
    Sheares, Karen K. K.
    Corriss, Paul A.
    Fisher, Andrew J.
    Lordan, James L.
    Gaine, Sean
    Coghlan, J. Gerry
    Wort, S. John
    Gatzoulis, Michael A.
    Peacock, Andrew J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (08) : 790 - 796
  • [34] Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial
    Torbicki, A.
    Mehta, S.
    Perchenet, L.
    Pulido, T.
    Sastry, B. K. S.
    Sitbon, O.
    Souza, R.
    Rubin, L. J.
    Simonneau, G.
    EUROPEAN HEART JOURNAL, 2013, 34 : 186 - 186
  • [35] Prognostic Indicators Of Long-Term Outcome In Pulmonary Arterial Hypertension: Results From The Seraphin Event-Driven Morbidity/mortality Trial
    Delcroix, M.
    Channick, R. N.
    Galie, N.
    Ghofrani, H. A.
    Jansa, P.
    Mehta, S.
    Perchenet, L.
    Pulido, T.
    Sastry, B.
    Sitbon, O.
    Souza, R.
    Torbicki, A.
    Verweij, P.
    Rubin, L. J.
    Simonneau, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [36] Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials-an Economic Evaluation Context: Methods, Limitations, and Recommendations
    Latimer, Nicholas R.
    Abrams, Keith R.
    Lambert, Paul C.
    Crowther, Michael J.
    Wailoo, Allan J.
    Morden, James P.
    Akehurst, Ron L.
    Campbell, Michael J.
    MEDICAL DECISION MAKING, 2014, 34 (03) : 387 - 402
  • [37] Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension Results of the Randomized IMPRES Study
    Hoeper, Marius M.
    Barst, Robyn J.
    Bourge, Robert C.
    Feldman, Jeremy
    Frost, Adaani E.
    Galie, Nazzareno
    Angel Gomez-Sanchez, Miguel
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Hassoun, Paul M.
    Morrell, Nicholas W.
    Peacock, Andrew J.
    Satoh, Toru
    Simonneau, Gerald
    Tapson, Victor F.
    Torres, Fernando
    Lawrence, David
    Quinn, Deborah A.
    Ghofrani, Hossein-Ardeschir
    CIRCULATION, 2013, 127 (10) : 1128 - +
  • [38] Elevated Pulmonary Arterial Compliance Is Associated with Survival in Pulmonary Hypertension: Results from a Novel Network Medicine Analysis
    Wang, Rui-Sheng
    Huang, Shi
    Waldo, Stephen W.
    Hess, Edward
    Gokhale, Madhura
    Johnson, Shelsey W.
    Zeder, Katarina
    Choudhary, Gaurav
    Leopold, Jane A.
    Oldham, William M.
    Kovacs, Gabor
    Freiberg, Matthew S.
    Tedford, Ryan J.
    Maron, Bradley A.
    Brittain, Evan L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (03) : 312 - 321
  • [39] Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: Impact of iloprost and bosentan treatment
    Dandel, Michael
    Lehmkuhl, Hans B.
    Mulahasanovic, Sead
    Weng, Yuguo
    Kemper, Dagmar
    Grauhan, Onnen
    Knosalla, Christoph
    Hetzer, Roland
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (09): : 898 - 906
  • [40] Improved survival after treatment with pulmonary vasodilator therapies in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
    Price, Laura
    Kouranos, Vasilis
    Baughman, Robert
    Bloom, Chloe
    Shlobin, Oksan
    Nathan, Steven
    Gupta, Rohit
    Mccabe, Colm
    Samaranayake, Chinthaka
    Mason, Thomas
    Renzoni, Elisabetta
    Wells, Athol
    Wort, John
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345